Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: Transient 'seronegative' antiphospholipid syndrome?

被引:0
|
作者
Miret, C
Cervera, R
Reverter, JC
GarciaCarrasco, M
Ramos, M
Molla, M
Font, J
Ingelmo, M
机构
[1] HOSP CLIN BARCELONA,SYSTEM AUTOIMMUNE DIS UNIT,BARCELONA 08036,SPAIN
[2] HOSP CLIN BARCELONA,DEPT HEMOTHERAPY & HEMOSTASIS,BARCELONA 08036,SPAIN
关键词
systemic lupus erythematosus; antiphospholipid syndrome; anticardiolipin antibody; lupus anticoagulant;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antiphospholipid syndrome (APS) is characterized by the presence of venous and arterial thrombosis, recurrent fetal losses and thrombocytopenia, associated with the presence of antiphospholipid antibodies (aPL). This syndrome may be ''primary'' or may be associated with other diseases, mainly systemic lupus erythematosus (SLE). However; some patients present the clinical picture of this syndrome but without evidence of aPL in their serum. The term ''seronegative'' APS has been proposed to categorize these patients. Herewith we present two patients with seronegativity for aPL at the time of a thrombotic event, but in whom these antibodies were detected 2 and 7 months later.
引用
收藏
页码:541 / 544
页数:4
相关论文
共 50 条
  • [31] A brief history of antiphospholipid antibodies and antiphospholipid syndrome
    Staub, Henrique Luiz
    Staub, Lia Portella
    SCIENTIA MEDICA, 2018, 28 (03)
  • [32] IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    Reshetnyak, Tatiana
    Cheldieva, Fariza
    Cherkasova, Maria
    Lila, Alexander
    Nasonov, Evgeny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [33] Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome
    Sanmarco, M.
    Boffa, M-C
    LUPUS, 2009, 18 (10) : 920 - 923
  • [34] 'Non-criteria antiphospholipid antibodies': bridging the gap between seropositive and seronegative antiphospholipid syndrome
    Truglia, Simona
    Mancuso, Silvia
    Capozzi, Antonella
    Recalchi, Serena
    Riitano, Gloria
    Longo, Agostina
    De Carolis, Sara
    Spinelli, Francesca Romana
    Alessandri, Cristiano
    Ceccarelli, Fulvia
    De Carolis, Caterina
    Misasi, Roberta
    Sorice, Maurizio
    Conti, Fabrizio
    RHEUMATOLOGY, 2022, 61 (02) : 826 - 833
  • [35] Management of Thrombotic Antiphospholipid Syndrome
    Chighizola, Cecilia Beatrice
    Raimondo, Maria Gabriella
    Meroni, Pier Luigi
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (05) : 419 - 426
  • [36] The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus
    Venturelli, Veronica
    Abrantes, Ana Mafalda
    Rahman, Anisur
    Isenberg, David A.
    RHEUMATOLOGY, 2024, 63 (SI) : SI72 - SI85
  • [37] THROMBOTIC MICROANGIOPATHY AND THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME
    DURAND, JM
    LEFEVRE, P
    KAPLANSKI, G
    SOUBEYRAND, J
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (12) : 1916 - 1918
  • [38] Antiphospholipid Syndrome
    George, Diane
    Erkan, Doruk
    PROGRESS IN CARDIOVASCULAR DISEASES, 2009, 52 (02) : 115 - 125
  • [39] Vasculitis in Antiphospholipid Syndrome
    Lally, Lindsay
    Sammaritano, Lisa R.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (01) : 109 - +
  • [40] Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome
    Shalamov, Michal Mia
    Kaufman, Lichay
    Simchen, Michal J.
    Agmon-Levin, Nancy
    Misgav, Mudi
    Orvieto, Raoul
    Machtinger, Ronit
    THROMBOSIS RESEARCH, 2024, 243